Significant Ownership of Redmile Group, LLC

Signature - Title
/s/ Jeremy C. Green - Managing Member
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Redmile Group, LLC.

Notify me when Redmile Group, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Redmile Group, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FATE FATE THERAPEUTICS INC Common Stock, par value $0.001 per share 14.9% $25.1M $175K 17.9M +0.7% Redmile Group, LLC Jul 2, 2025
ADCT ADC Therapeutics SA Common Shares, par value CHF 0.08 per share 14% $42M 15.7M Redmile Group, LLC Jun 30, 2025
SRRK Scholar Rock Holding Corporation Common Stock, par value $0.001 per share 9.9% $324M 9.89M Redmile Group, LLC Dec 31, 2024
RGNX REGENXBIO Inc. Common Stock, par value $0.0001 per share 9.9% $43.9M 5.06M Redmile Group, LLC Jun 30, 2025
NGNE Neurogene Inc. Common Stock, $0.000001 par value 9.9% $22.8M 1.48M Redmile Group, LLC Dec 31, 2024
RAPT RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share 9.9% $14.9M 1.77M Redmile Group, LLC Jun 30, 2025
RAPT RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share 9.9% $12.1M 13.9M Redmile Group, LLC Dec 31, 2024
ATRA Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $10.8M $659K 751K +6.53% Redmile Group, LLC Nov 12, 2025
STTK Shattuck Labs, Inc. Common Stock, par value $0.0001 per share 9.9% $5.42M $617K 6.38M +12.9% Redmile Group, LLC Aug 25, 2025
ALXO ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share 8.5% $2.04M 4.64M Redmile Group, LLC Jun 30, 2025
GRTS Gritstone bio, Inc. Common Stock, $0.0001 par value per share 8.2% $132K 13.2M Redmile Group, LLC Dec 31, 2024
STOK Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share 8% $52.6M 4.38M Redmile Group, LLC Jun 30, 2025
ABSI Absci Corporation Common Stock, $0.0001 par value per share 6.5% $25.3M 8.34M Redmile Group, LLC Apr 25, 2025
IMNM Immunome, Inc. Common Stock, $0.0001 Par Value 6.2% $45.7M 5.36M Redmile Group, LLC Mar 31, 2025
ZYME Zymeworks Inc. Common Stock, par value $0.00001 per share 4.9% $63.3M -$7.6M 3.71M -10.7% Redmile Group, LLC Sep 30, 2025
PLRX Pliant Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.8% $4.55M 2.9M Redmile Group, LLC Dec 31, 2024
Silence Therapeutics plc Ordinary Shares, nominal value GBP 0.05 per share 4.7% 6.64M -7.68% Redmile Group, LLC Mar 31, 2025
FOLD Amicus Therapeutics, Inc. Common Stock, par value $0.01 per share 4.6% $107M 14.2M Redmile Group, LLC Dec 31, 2024
REPL Replimune Group, Inc. Common Stock, par value $0.001 per share 0.7% $2.25M -$18.3M 536K -89.1% Redmile Group, LLC Sep 30, 2025
IGMS IGM Biosciences, Inc. Common Stock, par value $0.01 per share 0% $0 0 Redmile Group, LLC Aug 14, 2025

Schedules 13D/G Reported by Redmile Group, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.